Article

Svelte Medical Systems Announces CE Mark Certification of SLENDER IDS

15 Dec 2015

Svelte Medical Systems, Inc. today announced it received CE Mark certification of the SLENDER Sirolimus-Eluting Coronary Stent-On-A-Wire Integrated Delivery System (IDS) for the treatment of coronary artery disease.  The first advance in stent delivery since the rapid-exchange catheter...

Read the full article

Read more

  • Our products

    DSM portfolio of innovative biomedical materials and process manufacturing technologies: Biomedical Polyethylenes, Biomedical polyurethanes, Collagen Technology, Device Development, and Extracellular Matrix (ECM) Technology. Learn more.

  • The markets we serve

    DSM Biomedical offers the broadest portfolio of biomedical materials and manufacturing across market applications, including orthopedics, ophthalmology, neurology, cardiology, diabetes, wound, and continence care.

This site uses cookies to store information on your computer.

Learn more